-
March 23, 2024
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes
-
March 07, 2024
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells
-
October 04, 2023
Adoptive Transfer of Murine Engineered T Regulatory Cells Ameliorates Disease in a Model of Lipoplysaccharide Induced Acute Lung Injury
-
May 18, 2022
Generation of Islet-specific Engineered Regulatory T Cells (EngTregs) for Immune Tolerance Induction in Type 1 Diabetes Using a Novel Dual-editing Strategy
-
June 03, 2020
Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function
Toggle navigation